These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1661608)

  • 21. Influence of induction therapy on rejection and survival in heart transplantation.
    Almenar L; García-Palomar C; Martínez-Dolz L; Chamorro C; Moro J; Zorio E; Arnau MA; Rueda J; Osa A; Cardo ML
    Transplant Proc; 2005 Nov; 37(9):4024-7. PubMed ID: 16386616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The duration of administration of monoclonal antibody OKT3 for induction immunosuppression after heart transplantation.
    Aleksic I; Freimark D; Blanche C; Czer LS; Dalichau H; Valenza M; Takkenberg JJ; Trento A
    Thorac Cardiovasc Surg; 1997 Aug; 45(4):190-5. PubMed ID: 9323821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
    Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW
    J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.
    Wilde MI; Goa KL
    Drugs; 1996 May; 51(5):865-94. PubMed ID: 8861551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression.
    Melosky B; Karim M; Chui A; McBride M; Cameron EC; Yeung CK; Landsberg D; Shackleton C; Keown PA
    J Am Soc Nephrol; 1992 Jun; 2(12 Suppl):S290-4. PubMed ID: 1323341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies in renal transplantation: a review.
    Parlevliet KJ; Schellekens PT
    Transpl Int; 1992 Sep; 5(4):234-46. PubMed ID: 1418316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is induction therapy still needed in heart transplantation?
    Aliabadi A; Grömmer M; Zuckermann A
    Curr Opin Organ Transplant; 2011 Oct; 16(5):536-42. PubMed ID: 21836518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunosuppression after organ transplantation].
    Wagner K; Erhard J
    Zentralbl Chir; 1992; 117(12):648-52. PubMed ID: 1285470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steroid elimination-who, when, how?
    Matas AJ
    Transplant Proc; 2008 Dec; 40(10 Suppl):S52-6. PubMed ID: 19100910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy for acute rejection in pediatric organ transplant recipients.
    Debray D; Furlan V; Baudouin V; Houyel L; Lacaille F; Chardot C
    Paediatr Drugs; 2003; 5(2):81-93. PubMed ID: 12529161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic use of OKT3 in liver transplantation. A review.
    Fung J; Starzl T
    Dig Dis Sci; 1991 Oct; 36(10):1427-30. PubMed ID: 1914765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention and treatment of severe hemodynamic compromise in pediatric heart transplant patients.
    Costello JM; Pahl E
    Paediatr Drugs; 2002; 4(11):705-15. PubMed ID: 12390042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic strategies in immunosuppression after renal transplantation.
    Morris PJ
    J Pediatr; 1987 Dec; 111(6 Pt 2):1004-7. PubMed ID: 3316571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Coronary disease of transplanted heart. Physiopathology, prevention].
    Heim M; Nicolino-Peltier C; Metras D; Habib G; Kretmann B; Luccioni R; Bertault-Perez P
    Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():185-8. PubMed ID: 1337427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic allograft rejection: new developments in terminology, diagnosis, prevention, and treatment.
    Wiesner RH; Ludwig J; Krom RA; Hay JE; van Hoek B
    Mayo Clin Proc; 1993 Jan; 68(1):69-79. PubMed ID: 8417259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction therapy.
    Bakr MA
    Exp Clin Transplant; 2005 Jun; 3(1):320-8. PubMed ID: 15989677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ten years of Orthoclone OKT3 (muromonab-CD3): a review.
    Smith SL
    J Transpl Coord; 1996 Sep; 6(3):109-19; quiz 120-1. PubMed ID: 9188368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow transfusions in cadaver renal allografts: pilot trials with concurrent controls.
    Light J; Salomon DR; Diethelm AG; Alexander JW; Hunsicker L; Thistlethwaite R; Reinsmoen N; Stablein DM
    Clin Transplant; 2002 Oct; 16(5):317-24. PubMed ID: 12225426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction treatment with monoclonal antibodies for heart transplantation.
    Delgado JF; Vaqueriza D; Sánchez V; Escribano P; Ruiz-Cano MJ; Renes E; Gómez-Sánchez MA; Cortina JM; de la Calzada CS
    Transplant Rev (Orlando); 2011 Jan; 25(1):21-6. PubMed ID: 21126660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction immunosuppression.
    Kirk AD
    Transplantation; 2006 Sep; 82(5):593-602. PubMed ID: 16969280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.